9/5/2008
Most patients with diabetes have some degree of retinopathy, which may lead to severe disability if not treated or managed properly. On Friday, October 24, at 12:00 p.m., Cleveland Clinic ophthalmologist Rishi P, Singh, MD, will answer questions about diabetic retinopathy, discuss reasons why early screening is critical and discuss available treatment options.
Did you know?
- Diabetic retinopathy is the leading cause of blindness in American adults.
- There are no early warning signs diabetic retinopathy is developing, although gradual blurring of vision may occur.
- People with diabetes should have annual dilated eye exams to monitor for the development of problems in their vision.
- You don’t need to take your chances. Cleveland Clinic retina specialists are expert in crafting treatment plans that yield the best possible outcome – whether careful monitoring, medication or surgery.
You will have to register and log-in to access the live chat October 24. Take advantage of this opportunity to chat live with Dr. Singh in a secure online setting.
Ophthalmologist, Rishi P. Singh, MD
Diabetic Retinopathy
Friday, October 24, 2008
12:00 p.m.-1 p.m.
To pre-register for this chat and submit a question for Dr. Singh, click here.
More about Dr. Singh:
Rishi P. Singh, MD is a member of the Cleveland Clinic Cole Eye Institute’s Vitreoretinal Department. His primary specialty interests include surgical and medical treatment of the retina, macula and vitreous, with an emphasis on treating conditions such as diabetic retinopathy, age-related macular degeneration and retinal detachments. He is the principal investigator for numerous clinical trials of investigational treatments for retinal diseases. He is also Director of the Preclinical Compound Validation Program for the Cole Eye Institute, working on the next generation of medical and surgical therapeutics in ophthalmology.
Dr. Singh is a graduate of the seven-year combined B.A./MD program at Boston University and Boston University School of Medicine. He served his residency in ophthalmology at Massachusetts Eye and Ear Infirmary, Harvard University, Boston, and completed his vitreoretinal fellowship at Cleveland Clinic.
